IMP
Process View
negative regulation of endothelial cell development
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell development.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of endothelial cell development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TP63 | tumor protein p63 | 0.148 | ||
| GFRA4 | GDNF family receptor alpha 4 | 0.080 | ||
| HS3ST2 | heparan sulfate (glucosamine) 3-O-sulfotransferase 2 | 0.048 | ||
| ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | 0.045 | ||
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.034 | ||
| NEUROD2 | neurogenic differentiation 2 | 0.033 | ||
| CRHR2 | corticotropin releasing hormone receptor 2 | 0.032 | ||
| RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | 0.031 | ||
| RGS14 | regulator of G-protein signaling 14 | 0.031 | ||
| GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 0.029 | ||
| NCR2 | natural cytotoxicity triggering receptor 2 | 0.027 | ||
| FOXN1 | forkhead box N1 | 0.027 | ||
| GRIA4 | glutamate receptor, ionotrophic, AMPA 4 | 0.027 | ||
| CTRL | chymotrypsin-like | 0.026 | ||
| PITPNM3 | PITPNM family member 3 | 0.026 | ||
| CEACAM4 | carcinoembryonic antigen-related cell adhesion molecule 4 | 0.025 | ||
| AVPR1B | arginine vasopressin receptor 1B | 0.024 | ||
| CHIA | chitinase, acidic | 0.024 | ||
| HBQ1 | hemoglobin, theta 1 | 0.023 | ||
| GPR27 | G protein-coupled receptor 27 | 0.023 | ||
| ZNF835 | zinc finger protein 835 | 0.023 | ||
| CD5 | CD5 molecule | 0.022 | ||
| OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.022 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.022 | ||
| CD6 | CD6 molecule | 0.021 | ||
| GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | 0.021 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.020 | ||
| P2RX2 | purinergic receptor P2X, ligand-gated ion channel, 2 | 0.020 | ||
| GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | 0.019 | ||
| SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | 0.019 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.019 | ||
| TCL1B | T-cell leukemia/lymphoma 1B | 0.019 | ||
| ACAP1 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | 0.019 | ||
| GPR12 | G protein-coupled receptor 12 | 0.018 | Human | |
| TCL1A | T-cell leukemia/lymphoma 1A | 0.018 | ||
| CNTN2 | contactin 2 (axonal) | 0.018 | ||
| GFRA3 | GDNF family receptor alpha 3 | 0.017 | ||
| OPRL1 | opiate receptor-like 1 | 0.017 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.017 | ||
| FCHO1 | FCH domain only 1 | 0.017 | ||
| CD7 | CD7 molecule | 0.017 | ||
| JAK3 | Janus kinase 3 | 0.017 | ||
| VPREB3 | pre-B lymphocyte 3 | 0.017 | ||
| GJD2 | gap junction protein, delta 2, 36kDa | 0.017 | ||
| P2RX1 | purinergic receptor P2X, ligand-gated ion channel, 1 | 0.016 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.016 | ||
| LYL1 | lymphoblastic leukemia derived sequence 1 | 0.016 | ||
| PDE6G | phosphodiesterase 6G, cGMP-specific, rod, gamma | 0.016 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.016 | ||
| FUT1 | fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) | 0.016 | ||
| TKTL1 | transketolase-like 1 | 0.016 | ||
| NXPH4 | neurexophilin 4 | 0.016 | ||
| CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 | 0.016 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.016 | ||
| DAB1 | disabled homolog 1 (Drosophila) | 0.015 | ||
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.015 | ||
| GRM6 | glutamate receptor, metabotropic 6 | 0.015 | ||
| PNOC | prepronociceptin | 0.015 | ||
| B3GNT4 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 | 0.014 | ||
| TAC3 | tachykinin 3 | 0.014 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.014 | ||
| INA | internexin neuronal intermediate filament protein, alpha | 0.014 | ||
| OPN1SW | opsin 1 (cone pigments), short-wave-sensitive | 0.014 | ||
| ICOSLG | inducible T-cell co-stimulator ligand | 0.014 | ||
| KIF17 | kinesin family member 17 | 0.014 | ||
| CHIT1 | chitinase 1 (chitotriosidase) | 0.014 | ||
| POU2F2 | POU class 2 homeobox 2 | 0.013 | ||
| TRPM2 | transient receptor potential cation channel, subfamily M, member 2 | 0.013 | ||
| ADAM11 | ADAM metallopeptidase domain 11 | 0.013 | ||
| DENND1C | DENN/MADD domain containing 1C | 0.013 | ||
| CLC | Charcot-Leyden crystal protein | 0.013 | ||
| SLC22A14 | solute carrier family 22, member 14 | 0.013 | ||
| SH2D3C | SH2 domain containing 3C | 0.013 | ||
| KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 0.013 | ||
| RAB33A | RAB33A, member RAS oncogene family | 0.013 | ||
| POU3F1 | POU class 3 homeobox 1 | 0.013 | ||
| CLEC1A | C-type lectin domain family 1, member A | 0.013 | ||
| STMN4 | stathmin-like 4 | 0.013 | ||
| GPR15 | G protein-coupled receptor 15 | 0.013 | ||
| AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 0.013 | ||
| RIC3 | resistance to inhibitors of cholinesterase 3 homolog (C. elegans) | 0.013 | ||
| MC4R | melanocortin 4 receptor | 0.013 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.013 | ||
| FGF4 | fibroblast growth factor 4 | 0.012 | ||
| GH2 | growth hormone 2 | 0.012 | ||
| VSTM2A | V-set and transmembrane domain containing 2A | 0.012 | ||
| ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | 0.012 | ||
| COLEC12 | collectin sub-family member 12 | 0.012 | ||
| MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.012 | ||
| CA6 | carbonic anhydrase VI | 0.012 | ||
| GRAP | GRB2-related adaptor protein | 0.012 | ||
| NPY | neuropeptide Y | 0.012 | ||
| IL19 | interleukin 19 | 0.012 | ||
| RLBP1 | retinaldehyde binding protein 1 | 0.012 | ||
| GPR97 | G protein-coupled receptor 97 | 0.012 | ||
| TRPM8 | transient receptor potential cation channel, subfamily M, member 8 | 0.012 | ||
| GIMAP7 | GTPase, IMAP family member 7 | 0.012 | ||
| HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A | 0.012 | ||
| KCNA2 | potassium voltage-gated channel, shaker-related subfamily, member 2 | 0.012 | ||
| CXCR1 | chemokine (C-X-C motif) receptor 1 | 0.012 | ||
| CRH | corticotropin releasing hormone | 0.012 | ||
| ACTL7A | actin-like 7A | 0.012 | ||
| SLC5A5 | solute carrier family 5 (sodium iodide symporter), member 5 | 0.011 | ||
| PENK | proenkephalin | 0.011 | ||
| PRKCG | protein kinase C, gamma | 0.011 | ||
| GMIP | GEM interacting protein | 0.011 | ||
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.011 | ||
| FLT3 | fms-related tyrosine kinase 3 | 0.011 | ||
| DGKG | diacylglycerol kinase, gamma 90kDa | 0.011 | ||
| SSTR3 | somatostatin receptor 3 | 0.011 | ||
| DGKQ | diacylglycerol kinase, theta 110kDa | 0.011 | ||
| RTDR1 | rhabdoid tumor deletion region gene 1 | 0.011 | ||
| TRIM46 | tripartite motif containing 46 | 0.011 | ||
| HCN4 | hyperpolarization activated cyclic nucleotide-gated potassium channel 4 | 0.011 | ||
| NDP | Norrie disease (pseudoglioma) | 0.011 | ||
| JAM2 | junctional adhesion molecule 2 | 0.011 | ||
| CD1A | CD1a molecule | 0.011 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.011 | ||
| SH2B2 | SH2B adaptor protein 2 | 0.011 | ||
| GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 | 0.011 | ||
| CACNA1B | calcium channel, voltage-dependent, N type, alpha 1B subunit | 0.011 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.011 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.011 | ||
| AICDA | activation-induced cytidine deaminase | 0.010 | ||
| HAS2 | hyaluronan synthase 2 | 0.010 | ||
| MPP3 | membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) | 0.010 | ||
| KRT75 | keratin 75 | 0.010 | ||
| SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.010 | ||
| HRH3 | histamine receptor H3 | 0.010 | ||
| MEF2B | myocyte enhancer factor 2B | 0.010 | ||
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.010 | ||
| RNF122 | ring finger protein 122 | 0.010 | ||
| CD19 | CD19 molecule | 0.010 | ||
| RFX1 | regulatory factor X, 1 (influences HLA class II expression) | 0.010 |